Home > Insider Trading > Filing (0001042167-19-000006)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
863894	Veru Inc.	VERU	Pharmaceutical Preparations (2834)	391144397

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276244	Shuster Mitchell Steiner	4400 Biscayne Boulevard, Suite 888 Miami FL 33137	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-01-18	12,832	$1.34	7,751,935	No	4	S	Direct
Common Stock	Disposition	2019-01-23	12,768	$1.34	7,739,167	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	210,000	Indirect	Footnote 4

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person on December 18, 2018.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.33 to $1.35. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.29 to $1.36. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person's brother is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.